December 5, 2005
Boston Scientific Makes Surprise Bid for Guidant
Boston Scientific (BSX) has made a surprise bid to acquire Guidant for $72 per share, a premium of about 14 percent over the revised Johnson & Johnson/Guidant deal of $63.43 per share. GDT is currently trading at $67.25, up $5.43 from Friday’s close. Click here for a Reuters article with more details.
Update: BSX's bid is composed of $36 in cash and $36 in BSX stock. JNJ's original bid was $30.40 in cash and $45.60 in JNJ stock. JNJ's revised bid (post recall, etc.) stands at $33.25 in cash and $30.18 in JNJ stock. Click here for the BSX press release with more details.
TrackBack URL for this entry:
Listed below are links to weblogs that reference Boston Scientific Makes Surprise Bid for Guidant: